Online Intervention to Promote Resilience to Traumatic Stress During Pregnancy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Erin Berenz, PhD
- Phone Number: (312) 355-0808
- Email: eberenz@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60607
- University of Illinois Department of Psychology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- 18 years and older
- Pregnant and between 16-28 weeks gestation
- Are currently engaged in prenatal care with a healthcare provider (OB/GYN, nurse, midwife, etc.)
- Endorse a history of one or more potentially traumatic events meeting Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Criterion A for PTSD (i.e., "exposure to actual or threatened death, serious injury, or sexual violence," American Psychological Association [APA], p. 271) that is interpersonal in nature (e.g., sexual or physical assault, child abuse/maltreatment, witnessing family violence)
- Endorse a score of 33 or greater on the PTSD Checklist for DSM-5 (PCL-5)
- Have access to a broadband internet connection
- Able to read and speak English
Exclusion Criteria:
- Pregnant with multiples
- Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
- Have been diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
- Report currently being in an abusive or unsafe relationship
- Currently receiving treatment (medication or psychotherapy), or have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Sunnyside
An online intervention to better manage mood during and after pregnancy.
|
The Sunnyside intervention is an online intervention(an interactive website with didactic material and interactive tools) targeting skills to manage mood during and after pregnancy.
The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum.
Each lesson takes approximately 10 minutes to complete.
|
|
Experimental: SunnysideFlex
An online intervention to treat symptoms of PTSD and better manage mood during and after pregnancy.
|
SunnysideFlex consists of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum.
SunnysideFlex has adapted the original Sunnyside intervention with revised, trauma-focused content that covers the impact of PTSD symptoms on the perinatal period and daily functioning, more broadly
|
|
No Intervention: Treatment as Usual
A control condition consisting of standard prenatal medical care, without provision of the SunnysideFlex or Sunnyside intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PTSD Checklist for DSM-5 (PCL-5)
Time Frame: Past 30 days
|
The PCL-5 is a well validated screening tool for assessing PTSD symptoms and probable PTSD diagnosis.
the PCL-5 checklist assesses frequency of past 30-day PTSD symptoms in reference to an individual's self-identified worst traumatic event.
A total score of 33 or greater represents a positive PTSD screen and is the cut-off employed in the current study.
|
Past 30 days
|
|
Impact of Events Scale - Revised (IES-R)
Time Frame: 1 week
|
The IES-R assesses the past-week frequency of PTSD symptoms in reference to the participant's self-identified worst traumatic event
|
1 week
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 2 weeks
|
Reflects overall functioning and impairment due to the depressive symptoms.
PHQ-9 scoring interpretations are as follows: 1-4: minimal depressive symptoms; 5-9 mild depressive symptoms; 10-14: moderate depressive symptoms; 15-19: moderately severe depressive symptoms: 20-27: severe depressive symptoms.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jennifer Duffecy, PhD, University of Illinois at Chicago
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021-0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.